Skip to content

Clinical study for Ke Chuan Ting Ba Bu Ji acupoint application in the treatment of asthma recurrence: a Traditional Chinese Medicine rehabilitation trial

Clinical study for Ke Chuan Ting Ba Bu Ji acupoint application in the treatment of asthma recurrence: a Traditional Chinese Medicine rehabilitation trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016737
Enrollment
Unknown
Registered
2018-06-21
Start date
2018-07-01
Completion date
Unknown
Last updated
2018-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

Dermatitis group:Breathing exercises
No dermatitis group:Breathing exercises

Sponsors

Jiangsu Province Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. In line with the diagnostic criteria of asthma in western medicine, there is a clear history of recurrent asthma, Patients with intermittent seizures were in a non acute attack; 2. Conform to the above standard of TCM syndrome diagnosis; 3. The resident population of Nanjing has a fixed contact mode, with the possibility of follow-up and good compliance. 4. Asthma patients have received other treatments for more than 2 weeks.

Exclusion criteria

Exclusion criteria: 1. Combined with other severe cardiopulmonary diseases, bronchiectasis and pleural lesions; 2. Patients with severe primary diseases such as liver, kidney or hematopoietic system, mental and malignant tumors; 3. Diabetics with uncontrolled blood glucose; 4. In the past 1 months, we have used the medicine for improving the condition (such as budesonide, Xin Bi Ke Du Bao, etc.); 5. Skin allergies to adhesive tape, research medicine and excipients; 6. The injured skin or other diseases may affect the local medication, such as skin diseases; 7. Women who are lactating, gestation or preparing for pregnancy; 8. Anaphylaxis or allergy to Yunnan white ointment; 9. Nearly 3 months or participating in other experimental researchers; 10. According to the judgment of the researchers, other lesions or situations that have the possibility of reducing the possibility of entering the group or complicating the group, such as frequent changes in the working environment.

Design outcomes

Primary

MeasureTime frame
The difference of relapse and degree of asthma;ACT;AQLQ;PEF;pulmonary function detector;

Countries

China

Contacts

Public ContactWang Hesheng

Jiangsu Province Hospital of Chinese Medicine

wanghesheng2010@126.com+86 13852944238

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026